Skip to main content
Equibles

NISA INVESTMENT ADVISORS, LLC

Position in PRLD — Prelude Therapeutics Inc

CIK 937615 ST. LOUIS, MO
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$8,709
+$3,121 QoQ
Shares Held
1,634
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 75 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,553,099 across 265 Biotechnology names. PRLD ranks #174 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 56,455 $28,042,892
2 REGN
Regeneron Pharmaceuticals, Inc.
 19,412 $12,104,158
3 TECH
BIO-TECHNE Corp
 68,452 $4,836,133
4 INCY
Incyte Corp
 26,479 $3,001,659
5 ALNY
Alnylam Pharmaceuticals, Inc.
 9,139 $2,751,113
6 DFTX
Definium Therapeutics, Inc.
 48,369 $2,275,277
7 PRAX
Praxis Precision Medicines, Inc.
 6,111 $2,045,901
8 EXEL
Exelixis, Inc.
 36,758 $2,000,002

All Filings in PRLD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,709 1,634
2026-03-31 $5,588 1,634
2025-12-31 $4,738 1,634
2025-09-30 $2,352 1,634
2025-06-30 $1,321 1,634
2025-03-31 $307 400
2024-12-31 $647 508
2024-06-30 $8,001 2,100
2023-09-30 $114 37
2023-06-30 $18,000 4,000
2023-03-31 $22,800 4,000
2022-12-31 $24,160 4,000
2022-09-30 $26,440 4,000
2022-06-30 $20,880 4,000